China Glucosamine Supplements Market Size & Outlook, 2026-2034
China Glucosamine Supplements Market Insights
- As highlighted in Deep Market Insights analysis, the China Glucosamine Supplements Market, worth USD 11.97 billion in 2025, is forecasted to achieve USD 22.72 billion by 2034.
- The China market is anticipated to grow at a CAGR of 7.33% during the period 2026–2034.
- By 2025, Capsule represented the largest share of the By Type market size.
- Capsule is expected to remain the key growth driver within By Type, registering the fastest CAGR during the forecast period.
![China Glucosamine Supplements Market Size, Share & Growth Analysis By [2034]](https://deepmarketinsights.com/uploads/charts/china-glucosamine-supplements-market-china-by-type-297942.png)
Source: DMI Analysis Company Publications, Primary Interviews.
Other Key Findings
- China accounted for 8.96% of the global Glucosamine Supplements Market size in 2025.
- By 2034, United States is expected to remain the top global market in terms of size.
- Within Asia Pacific, China is forecasted to dominate the regional Glucosamine Supplements Market size by 2034.
- India will be the fastest-growing market in Asia Pacific, projected to achieve USD 11.62 billion by 2034.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2025 |
| Study Period | 2022-2034 |
| Historical Period | 2022-2024 |
| Forecast Period | 2026-2034 |
| Market Size In 2025 | USD 11.97 billion |
| Market Size In 2034 | USD 22.72 billion |
| Largest segment | Capsule |
| Units | Revenue in USD billion |
| CAGR | 7.33% (2026-2034) |
| Segmnetation Covered | |
| By Type |
|
| By Application |
|
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
China Glucosamine Supplements Market By Type 2026-2034 (USD billion)
| By Type | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capsule | XX.x | XX.x | XX.x | 6.76 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Pill | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
China Glucosamine Supplements Market By Application 2026-2034 (USD billion)
| By Application | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Osteoarthritis | XX.x | XX.x | XX.x | 7.77 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Nutritional Dietary Supplements | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.